XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Total
Common Shares Outstanding
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Deferred Equity Compensation
Nonredeemable Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023     56,217,305        
Beginning balance at Dec. 31, 2023 $ 5,765 $ 5,713 $ 1 $ 6,070 $ (359) $ 1 $ 52
Increase (Decrease) in Shareholders' Equity              
Net income 113 109   109     4
Dividends (19) (19)   (19)      
Common share repurchases (in shares)     (1,539,278)        
Common shares repurchases (131) (131)   (131)      
Share-based compensation (in shares)     403,557        
Share-based compensation (15) (15)   (15)      
Distributions (3)           (3)
Other comprehensive (loss) income (28) (28)     (28)    
Ending balance (in shares) at Mar. 31, 2024     55,081,584        
Ending balance at Mar. 31, 2024 5,682 5,629 $ 1 6,014 (387) 1 53
Beginning balance (in shares) at Dec. 31, 2024     50,505,320        
Beginning balance at Dec. 31, 2024 5,553 5,495 $ 1 5,878 (385) 1 58
Increase (Decrease) in Shareholders' Equity              
Net income 185 176   176     9
Dividends (18) (18)   (18)      
Common share repurchases (in shares)     (1,335,228)        
Common shares repurchases (120) (120) $ (1) (119)      
Share-based compensation (in shares)     383,346        
Share-based compensation (14) (14)   (14)      
Other comprehensive (loss) income 71 71     71    
Ending balance (in shares) at Mar. 31, 2025     49,553,438        
Ending balance at Mar. 31, 2025 $ 5,657 $ 5,590 $ 0 $ 5,903 $ (314) $ 1 $ 67